Prostate Carcinoma
139
37
63
44
Key Insights
Highlights
Success Rate
79% trial completion
Published Results
14 trials with published results (10%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.6%
12 terminated out of 139 trials
78.6%
-8.0% vs benchmark
4%
6 trials in Phase 3/4
32%
14 of 44 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 44 completed trials
Clinical Trials (139)
Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men
Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men
Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer
A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men
Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer
Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer
Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer
Long-Term Follow-Up in Patients With Prostate Cancer After Surgery
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring
The Vanguard Study: Testing a New Way to Screen for Cancer
MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial
Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer
Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation